← FDA Drug Approvals (Drugs@FDA)

JADENU SPRINKLE

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2017-05-18

Drug application

FDA Application #
NDA207968
Application type
New Drug Application
Brand name
JADENU SPRINKLE
Generic name
DEFERASIROX
Active ingredients
DEFERASIROX
Dosage form
GRANULE
Route
ORAL
Marketing status
Prescription
Sponsor
NOVARTIS
Manufacturer
Novartis Pharmaceuticals Corporation
First approval
2017-05-18

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown